Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

Benzinga.com  February 22, 2019

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response

Business Wire February 14, 2019

Bio-Rad to Report Fourth-Quarter and Full-Year 2018 Financial Results Thursday, February 28, 2019

Business Wire February 12, 2019

Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019

Business Wire January 3, 2019

Bio-Rad to Participate at the 37th Annual J.P. Morgan Healthcare Conference on January 8

Business Wire January 2, 2019

The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede

Benzinga.com  December 27, 2018

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

Benzinga.com  December 21, 2018

Bio-Rad Quality Controls Now Available for Multiple Abbott Clinical Diagnostics Platforms

Business Wire December 3, 2018

New Research Coverage Highlights Omeros, Apple, Bio-Rad Laboratories, Cott, Darling Ingredients, and Osisko Gold Royalties — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire November 30, 2018

Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies

Business Wire November 14, 2018

Bio-Rad Wins USDA Contract for Its Pathogen Detection Testing Products

Business Wire November 13, 2018

Bio-Rad Reports Third-Quarter 2018 Financial Results

Business Wire November 1, 2018

Bio-Rad Receives U.S. FDA Clearance for the IH-Reader 24, Expanding the Company’s Offering for the Blood Typing Market

Business Wire October 29, 2018

Bio-Rad to Report Third-Quarter 2018 Financial Results Thursday, November 1, 2018

Business Wire October 9, 2018

Bio-Rad to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference on September 12

Business Wire August 29, 2018

Bio-Rad Reports Second-Quarter 2018 Financial Results

Business Wire August 7, 2018

Bio-Rad to Report Second-Quarter 2018 Financial Results Tuesday, August 7, 2018

Business Wire July 16, 2018

Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5

Business Wire May 30, 2018

Benzinga's Daily Biotech Pulse: Insmed Presents Data, Pfenex Pulls Back On Offering, Oncolytics Listing

Benzinga.com  May 23, 2018

Research Report Identifies Bio-Rad Laboratories, Bright Horizons Family Solutions, Corbus Pharmaceuticals, PennyMac Financial Services, TeleTech, and Matrix Service with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire May 18, 2018